Dr. Reddys Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Its cash flow management also looks well with steady cash flow generation at the operational level and investing the cash in assets and income earning investments. The company’s shares trade at 31.2x of its earnings and delivers 13.4%. Keeping in mind the company’s performance and future prospects we give a Buy.
Download Full Report
